National Drug Authority is gov’t agency that promotes & protects public health through effective regulation of human, animal medicines & healthcare products.
📍11th National AMR Conference | Hotel Africana, Kampala | 18–19 November
Uganda’s AMR stakeholders have come together under the theme “One Health, One Action: Prevent AMR Now!” to strengthen partnerships and accelerate action against antimicrobial resistance.
👏 Shout-out to all participating stakeholders, partners and sponsors for driving this important agenda.
Use antimicrobials responsibly, prevent infections and take action against AMR. Every action counts!
#WAAW2026#OneHealth#AMR#PreventAMRNow#NDAUganda
Join us from 18–24 November as we mark World AMR Awareness Week.
Antimicrobial resistance affects humans, animals, plants and the environment. Preventing it requires collective action across all sectors.
Use antimicrobials responsibly, prevent infections, and help protect their effectiveness for generations to come.
One Health. One Action. Prevent AMR Now!
#WAAW2026#AMR#OneHealth#PreventAMRNow#AntimicrobialResistance#NDAUganda
We are on the last day of our stakeholders engagement themed on "Integrating Digital Pharmacovigilance (PV) into Uganda's Consolidated HIV guidelines" which began yesterday, 12 November.
We have held presentations and conducted a review of the draft chapter with key recommendations, reporting procedures, and implementation requirements on PV digital integration.
During this two-day meeting, the teams have emphasized the importance of strengthened PV and support for existing drug safety reporting and monitoring systems while embracing digital platforms such as #MedSafetyApp#VigiMobile at both facility and community levels.
This initiative prioritizes the improved identification, management, documentation, and timely reporting of suspected adverse drug reactions (ADRs) to the @UNDAuthority.
Notable remarks were provided by; Ms. Sarah Nakimbugwe (a Project Coordinator from @Makerere – Department of Pharmacology and Therapeutics), Mr. @Juliomayengo, Mr. @Ntale_Ismail_K, Dr. Mwesigwa Douglas (@Dugiy2), Mr. @JosephEmiku, Dr. Izidoro Sunday, and Albert Nasasira, etc.
Remarks of Dr Ronald Kiguba, an Associate Professor @MakerereCHS at the stakeholders' engagement on pharmacovigilance (PV):
"The journey of digitizing pharmacovigilance in Uganda has come a long way, starting with the introduction of E-reporting (using an online form) developed by @WHO-UMC to the use of social platforms like WhatsApp, and more recently mobile apps like Med Safety App and VigiMobile."
In this stakeholders' workshop, we now want to integrate digital tools such as the Med Safety App into the consolidated guidelines for the prevention and treatment of HIV in Uganda.
Participants have been drawn from @Makerere@MakerereCHS, @IDIMakerere@Lung_Institute@mujhu_care_ltd@MakSPH@MakCHS_SOM@MinofHealthUG (HIV prevention and care programs from the AIDS/STI Control Division), @mofpedU@TheGFUCCM@JMSUganda@nmsuganda@bayloruganda and @UNDAuthority.
The ultimate objective is to improve the efficiency of drug safety monitoring in Uganda.
#ReportSideEffects#Pharmacovigilance#HIVDrugSafety#SafeMedicines#PatientSafety
On identifying gaps and opportunities for integrating digital pharmacovigilance into the HIV guidelines, Ms Sarah Nakimbugwe from @MakerereCHS cites several cases of a lack of information on the reporting tools, inadequate access to reliable data, affordability, and delayed feedback. She emphasizes the importance of supporting existing strategies and enabling their effectiveness rather than adopting new elements that risk parallel structures of activity.
#ReportSideEffects#Pharmacovigilance#HIVDrugSafety#SafeMedicines#PatientSafety
Today, teams from @MakerereUniversity, @UNDAuthority, @MinofHealthUG AIDS/STI Control Division, and the Department of Pharmaceuticals and Natural Medicines are holding a two-day workshop on integrating digital pharmacovigilance into Uganda's consolidated HIV guidelines.
In this relevant meeting, the teams, led by Dr. Helen B. Ndagije (@NDAProductSafe), Dr. Harriet Akello (Ag. ACHS Pharmaceutical Quality Assurance at @MinofHealthUG), ACP @IanNyamitoro (AIDS/STI Control Division), and Dr. Ronald Kiguba (an associate professor at @MakerereCHS), aim to develop practical guidance and implementation tools for integrating digital pharmacovigilance into routine HIV care, with an emphasis on improving the identification, documentation, and timely reporting of suspected adverse drug reactions (ADRs) and other drug-related problems to @UNDAuthority.
#ReportSideEffects#Pharmacovigilance#DrugSafety#PatientSafety
Govt appoints board to oversee new drug regulatory authority
Dr Christine Kirunga Tashobya to head new body regulating medicines and health products.
monitor.co.ug/uganda/news/na…
UGANDA TAKES ITS PLACE IN SHAPING AFRICA’S MEDICINES REGULATORY AGENDA
National Drug and Health Products Authority experts appointed to African Medicines Agency Technical Committees
The National Drug and Health Products Authority (NDHPA) is pleased to announce Uganda’s representation on the Technical Committees of the African Medicines Agency (AMA), marking an important milestone in the country’s contribution to strengthening medicines regulation and advancing public health across Africa.
Two of Uganda’s regulatory experts, Dr Amoreen Naluyima and Dr Helen Byomire Ndagije, have been appointed to serve on three important technical committees of the African Medicines Agency.
Their appointments are as follows:
* Dr Amoreen Naluyima – Quality Control Laboratories and Laboratory Networks Technical Committee.
* Dr Helen Byomire Ndagije – Clinical Trials Oversight and Good Clinical Practice Technical Committee.
* Dr Helen Byomire Ndagije – Market Intelligence and Control Technical Committee.
These appointments recognise the technical expertise developed within Uganda’s regulatory system and provide an important platform for the country to contribute to continental regulatory policy, scientific decision-making and regulatory harmonisation.
Strengthening Africa’s regulatory capacity
The African Medicines Agency is a landmark continental initiative established to strengthen the capacity of African countries to regulate medical products and improve access to safe, effective and quality-assured medicines and other health products.
Its Technical Committees provide independent scientific and technical advice to support regulatory assessments, clinical trials oversight, quality assurance, market intelligence and control, and other critical regulatory functions.
Uganda’s representation across laboratory quality systems, clinical trials oversight and market control is particularly significant. These functions are central to ensuring that medical products entering and circulating in African markets meet the required standards of quality, safety and efficacy.
From national expertise to continental impact
For the newly established National Drug and Health Products Authority, these appointments reflect an important opportunity to extend Uganda’s regulatory contribution beyond national borders.
They also reinforce the importance of investing in regulatory science, developing technical capacity and fostering collaboration among African regulatory authorities.
As Africa continues to strengthen its pharmaceutical manufacturing capacity, expand clinical research and improve access to innovative health technologies, strong regulatory institutions and competent scientific experts will remain essential to protecting public health.
The Authority congratulates Dr Amoreen Naluyima and Dr Helen Byomire Ndagije on these appointments. We look forward to their contribution to the work of the African Medicines Agency and to advancing a stronger, more harmonised and responsive regulatory environment for Africa.
Uganda is not only strengthening its national regulatory system; it is contributing expertise to shape the future of medicines regulation across Africa.
Together, let us advance regulatory excellence, scientific collaboration and equitable access to quality-assured medical products for all Africans.
#NDHPA#AfricanMedicinesAgency#AMA#Uganda#MedicinesRegulation#RegulatoryScience#ClinicalTrials#QualityAssurance#MarketSurveillance#RegulatoryHarmonisation#PublicHealth
Some side effects may only develop after using a medicine for a long time. Others may not appear until after you've stopped treatment, changed dose, or started taking more than one medicine.
Whether side effects appear quickly or after a longer period, don’t ignore them – report them on WhatsApp; 0740002070 or click the link to report online nda.or.ug/adrs-aefis-reporti…#MedSafetyWeek#ReportSideEffects#PatientSafety
👀 What do side effects look like?
Some may appear as:
→ Skin changes
→ Stomach or digestion problems
→ Sleep or mood changes
→ Breathing or heart symptoms
→ Changes identified through tests
As a patient, parent, or caregiver, knowing how side effects may appear can help you spot them. Read the patient information leaflet supplied with the medicine and talk to a healthcare professional about new, unusual, or persistent symptoms.
Don’t ignore side effects – click the link to report them to us. vigiflow-eforms.who-umc.org/…#MedSafetyWeek#PatientSafety
There are many kinds of side effects, don't ignore them. Report them on; Toll free 0800101999, WhatsApp 0740002070, Email; druginfo@nda.or.ug or tap the link to repot online: nda.or.ug/adrs-aefis-reporti…#MedSafetyWeek
Join the #medsafetyweek campaign from 2nd to 8th November! Help spread the word by sharing our campaign post, raising awareness and encouraging safer use of medicines. Every share counts towards safer healthcare for all. #MedSafetyWeek
We are happy to share with you our September 2026 Directorate of Laboratory Services Spectrum. For details, follow the link attached.
As emphasized by our ED, NDA’s Pharmacutical Quality Control Laboratory remains central in ensuring that we deliver to Ugandans good quality and safe medicines and medical devices that work well (efficacious).
drive.google.com/file/d/1O_8…